BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26

• Drug Development

  Interim Analysis of Top-Line Data From Phase II/III Study Shows Favorable Efficacy & Safety for Corthera’s Relaxin in Acute Heart Failure

  November 10, 2008

   · 

  4 min read
• Drug Development

  VIA Pharmaceuticals, Inc. Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease - In Two Studies Drug was Well-Tolerated, Significantly Inhibited Leukotriene Production, and Reduced Inflammation- - Webca

  November 10, 2008

   · 

  9 min read
• Pharm Country

  Regeneron Pharmaceuticals, Inc. Announces Presentation at the Credit Suisse 2008 Healthcare Conference

  November 10, 2008

   · 

  1 min read
• Business

  ArQule, Inc. and Daiichi Sankyo Co Ltd. Enter Into Strategic R&D Partnership to Progress Novel Compounds to Target Cancer; Total Cash Upfront to ArQule is $75M

  November 10, 2008

   · 

  9 min read
• Drug Development

  Potentia Pharmaceuticals, Inc.’ Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial AMD Patients Treated with POT-4 Demonstrate No Adverse Toxic Effects

  November 10, 2008

   · 

  3 min read
• Drug Development

  Celladon Corporation Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions Phase 1 Data Demonstrate Safety and Improvement in Heart Failure in a Majority o

  November 10, 2008

   · 

  5 min read
• BioMidwest

  Allos Therapeutics, Inc. Release: Four Pralatrexate (PDX) Studies to Be Presented at the 50th Annual Meeting of the American Society of Hematology

  November 10, 2008

   · 

  1 min read
• Genetown

  The Boston Globe Names Cubist Pharmaceuticals, Inc. to Globe 100’s Top Places to Work ‘08

  November 10, 2008

   · 

  1 min read
• Santaris Pharma A/S Releases Positive Data on LNA-based Survivin Inhibitor

  November 10, 2008

   · 

  1 min read
• Pharm Country

  Safeguard Scientifics and Oxford Bioscience Partners Co-Lead $12 Million Series a Financing for Molecular Biometrics

  November 10, 2008

   · 

  6 min read